Skip to main content
Give
Edit Icon - Click to update your profileUpdate Your Profile

Robert C. Miller, MD

Academic Title:

Professor

Primary Appointment:

Radiation Oncology

Administrative Title:

Director, Dr. Nancy K. Welker Fellowship in Advanced Radiation Modalities - Department of Radiation Oncology; Medical Director, Maryland Proton Treatment Center

Additional Title:

Professor, Department of Radiation Oncology, University of Maryland School of Medicine; Medical Director, Maryland Proton Treatment Center

Email:

RobertMiller@umm.edu

Location:

Maryland Proton Treatment Center, BioPark, 850 W. Baltimore Street, Baltimore, Maryland, 21201

Phone (Primary):

410-369-5200

Download CV

Education and Training

Education

1983-1985            B.S. in Business Administration (cum laude), University of Tulsa

1985-1987            B.S. in Engineering Physics, University of Tulsa

1987-1990            M.S. in Radiological Medical Physics, honors, University of Kentucky

1989-1993            M.D., with distinction, University of Kentucky

2011-2013            MBA, Oxford University, Oxford, U.K.

 

Post Graduate Education and Training

1993-1994            Internship, Department of Internal Medicine, University of Kentucky

1994-1998            Residency, Department of Radiation Oncology, Mayo Clinic, Rochester, MN

Biosketch

Professor Miller has conducted extensive clinical research on the use of compounds to mitigate the risk of normal tissue injury in patients undergoing radiation therapy. He has served as the national principal investigator/study chairman for five NIH funded national Phase III cooperative group clinical trials using these agents. Priot to joining the faculty of the University of Maryland School of Medicine, he retired from the Mayo Clinic in 2019 after twenty five years of service where he served as Vice Chair of Mayo Clinic Cancer Center National Practice Committee, overseeing cancer care delivery at all of Mayo’s national sites. He previously served as Vice Chairman of the Board of Trustees of the Albert and Lea Austin Mayo Clinic Health System.  

At the University of Maryland, Dr. Miller serves as Medical Director of the Maryland Proton Treatment Center.  MPTC is the first center in the Baltimore-Washington region to offer proton therapy, a highly advanced and precise form of radiation, to treat cancer. MPTC’s facility, which began treating patients since February 2016, offers the next generation in proton therapy, called pencil-beam scanning or intensity-modulated proton therapy (IMPT), in all five treatment rooms. This offers patients the most precise treatment available. Proton therapy delivers an increased dose that stops specifically at the tumor site. As a result, it protects much of the surrounding, normal tissue. It is painless, non-invasive and well tolerated which often times leads to fewer side effects now and in the future.  Previously, Dr. Miller was Vice Chair for Research of the Mayo Clinic Department of Radiation Oncology in Rochester, Minnesota, focusing on proton therapy clinical trial development, and more recently, from 2018-2019, Medical Director for Particle Therapy at Mayo Clinic Florida.

Dr. Miller is the author of more than 175 peer-reviewed papers. He is the founding Editor in Chief of the American Society for Radiation Oncology’s (ASTRO’s) third academic journal, Advances in Radiation Oncology. He also serves as a non-executive director of Tekcapital plc and has a background in commercialization of university generated intellectual property. Dr. Miller began his scientific career as a medical physicist at the University of Kentucky, before going on to graduate from medical school at the University of Kentucky. Dr. Miller also received an MBA Degree from Oxford University in the United Kingdom.

Research/Clinical Keywords

Proton radiotherapy, Medical countermeasures, Symptom control in cancer care

Highlighted Publications

  •  Sio T, Le-Rademacher J, Leenstra J, Loprinzi C, Rine G, Curtis A, Singh A, Martenson J, Novotny P, Tan A, Qin R, Reiter P, Miller RC. A Phase III Randomized, Double-Blind Study of Doxepin Rinse versus Diphenhydramine-Lidocaine-Antacid (DLA) Mouthwash versus Placebo in the Treatment of Acute Oral Mucositis Pain for Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304).  JAMA, in press, April 16, 2019.
  • Leenstra JL, Miller RC, Qin R, Martenson JA, Dornfeld KJ, Bearden JD, Puri DR, Stella PJ, Mazurczak MA, Klish MD, Novotny PJ, Foote RL, Loprinzi CL.  Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). J Clin Oncol. 2014 May 20; 32 (15):1571-7 Epub 2014 Apr 14 PMID: 24733799   PMCID: 4026580   DOI: 10.1200/JCO.2013.53.2630.
  • Miller RC, Petereit DG, Sloan JA, Liu H, Martenson JA, Bearden JD 3rd, Sapiente R, Seeger GR, Mowat RB, Liem B, Iott MJ, Loprinzi CL, Alliance for Clinical Trials in Oncology.  N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Jul 15; 95 (4):1168-74 Epub 2016 Apr 23 PMID: 27354129   PMCID: 4955745   DOI: 10.1016/j.ijrobp.2016.01.063
  • Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Stoffel TJ, Haselow RE, Schaefer PL, Bearden JD 3rd, Atherton PJ, Loprinzi CL, Martenson JA. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79 (5):1460-6 Epub 2010 Aug 26 PMID: 20800381   PMCID: 2995007   DOI: 10.1016/j.ijrobp.2010.01.031
  • Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen, Williams JP, Nichols CR, Einhorn LH, Fossa SD. Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst. 2010 Aug 4; 102(15):1114-30. Epub 2010 Jun 28. PMID: 20585105   PMCID: 2914759   DOI: 10.1093/jnci/djq216

 

Additional Publication Citations

  1. Miller RC, Wilson KG, Feola JM, Urano M, Yaes RJ, McLaughlin P, Maruyama Y. Megavoltage grid total body irradiation of C3Hf/SED mice. Strahlenther Onkol. 1992 Jul; 168(7):423-6. PMID: 1496454     
  2. Urano M, Majima H, Miller R, Kahn J. Cytotoxic effect of 1,3 bis (2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis and tumour response. Int J Hyperthermia. 1991 May-Jun; 7(3):499-510. PMID: 1919145  
  3. Miller RC, Foote RL, Coffey RJ, Gorman DA, Earle JD, Schomberg PJ, Kline RW. The role of stereotactic radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys. 1997 Dec 1; 39(5):977-81. PMID: 9392534     
  4. Miller RC, Bonner JA, Wenger DE, Foote RL, Kisrow KL, Shaw EG. Spinal cord localization in the treatment of lung cancer: use of radiographic landmarks. Int J Radiat Oncol Biol Phys. 1998 Jan 15; 40: (2)347-51. PMID: 9457820     
  5. Miller RC, Martenson JA, Sargent DJ, Kahn MJ, Krook JE. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma. Int J Radiat Oncol Biol Phys. 1998 Jun 1; 41(3):593-8. PMID: 9635707     
  6. Miller RC, Bonner JA, Kline RW. Impact of beam energy and field margin on penumbra at lung tumor-lung parenchyma interfaces. Int J Radiat Oncol Biol Phys. 1998 Jun 1; 41(3):707-13. PMID: 9635723     
  7. Miller RC, Foote RL, Coffey RJ, Sargent DJ, Gorman DA, Schomberg PJ, Kline RW. Decrease in cranial nerve complications after radiosurgery for acoustic neuromas: a prospective study of dose and volume. Int J Radiat Oncol Biol Phys. 1999 Jan 15; 43(2):305-11. PMID: 10030254     
  8. Miller RC, Sargent DJ, Martenson JA, MacDonald JS, Haller D, Mayer RJ, Gunderson LL, Rich TA, Cha SS, O'Connell MJ. Acute diarrhea during adjuvant therapy for rectal cancer: A detailed analysis from a randomized intergroup trial. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54(2):409-13. PMID: 12243815     
  9. Gold DG, Miller RC. Metastatic thymoma: A case report of an isolated, intra-abdominal metastasis causing asymptomatic spinal cord compression. Radiother Oncol. 2005; 39(2):141-6, 164. PMID: 0     
  10. Brown PD, Foote RL, McLaughlin MP, Halyard MY, Ballman KV, Collie AC, Miller RC, Flemming KD, Hallett JW. A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2005 Dec 01; 63: (5)1361-7. PMID: 16169673   DOI: 10.1016/j.ijrobp.2005.05.046  
  11. McKian KP, Miller RC, Cassivi SD, Jatoi A. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy. Dis Esophagus. 2006; 19: (6)448-53. PMID: 17069587   DOI: 10.1111/j.1442-2050.2006.00611.x  
  12. Miller RC, Haddock MG, Gunderson LL, Donohue JH, Trastek VF, Alberts SR, Deschamps C. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus. 2006; 19: (6)487-95. PMID: 17069594   DOI: 10.1111/j.1442-2050.2006.00626.x  
  13. Bhatia S, Miller RC, Lachance DL. Neck extensor muscle weakness (Dropped head syndrome) following radiotherapy. Radiology & Oncology. 2006; 40(1):29-33, 60. PMID: 0     
  14. Miller RC, Haddock MG, Petersen IA, Gunderson LL, Furth AF. Intraoperative electron-beam radiotherapy and ureteral obstruction. Int J Radiat Oncol Biol Phys. 2006 Mar 1; 64(3):792-8. Epub 2005 Oct 21. PMID: 16243445   DOI: 10.1016/j.ijrobp.2005.08.019  
  15. Pilepich MV, Paulus R, St Clair W, Brasacchio RA, Rostock R, Miller RC. Phase III study of pentosanpolysulfate (PPS) in treatment of gastrointestinal tract sequelae of radiotherapy. Am J Clin Oncol. 2006 Apr; 29(2):132-7. PMID: 16601430   PMCID: 0   DOI: 10.1097/01.coc.0000203758.77490.fd
  16. Monnard V, Sun A, Epelbaum R, Poortmans P, Miller RC, Verschueren T, Scandolaro L, Villa S, Majno SB, Ostermann S, Ozsahin M, Mirimanoff RO. Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2006 Jul 1; 65(3):817-23. Epub 2006 Mar 15. PMID: 16542791   PMCID: 0   DOI: 10.1016/j.ijrobp.2006.01.002
  17. Omlin A, Amichetti M, Azria D, Cole BF, Fourneret P, Poortmans P, Naehrig D, Miller RC, Krengli M, Gutierrez Miguelez C, Morgan D, Goldberg H, Scandolaro L, Gastelblum P, Ozsahin M, Dohr D, Christie D, Oppitz U, Abacioglu U, Gruber G. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol. 2006 Aug; 7(8):652-6. PMID: 16887482   DOI: 10.1016/S1470-2045(06)70765-3  
  18. Weber DC, Miller RC, Villa S, Hanssens P, Baumert BG, Castadot P, Varlet P, Abacioglu U, Igdem S, Szutowicz E, Nishioka H, Hofer S, Rutz HP, Ozsahin M, Taghian A, Mirimanoff RO. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2006 Sep 1; 66(1):179-86. Epub 2006 Jul 11. PMID: 16814953   DOI: 10.1016/j.ijrobp.2006.04.035  
  19. Miller RC, Villa S, Kamer S, Pasquier D, Poortmans P, Micke O, Call TG. Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study. Radiother Oncol. 2006 Sep; 80(3):323-6. Epub 2006 Sep 07. PMID: 16959346   DOI: 10.1016/j.radonc.2006.07.034  
  20. Bhatia S, Miller RC, Haddock MG, Donohue JH, Krishnan S. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2006 Oct 1; 66(2):514-9. Epub 2006 Jul 25. PMID: 16863684   DOI: 10.1016/j.ijrobp.2006.04.018  
  21. Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioglu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol. 2006 Oct; 81(1):39-46. Epub 2006 Sep 11. PMID: 16965827   DOI: 10.1016/j.radonc.2006.08.019  
  22. Miller RC, Lachance DH, Lucchinetti CF, Keegan BM, Gavrilova RH, Brown PD, Weinshenker BG, Rodriguez M. Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1178-86. Epub 2006 Sep 11. PMID: 16965867   DOI: 10.1016/j.ijrobp.2006.06.014  
  23. * Pinn ME, Austin LM, Schomas DA, Miller RC. Case report from Mayo Clinic: Locally advanced Bartholin gland carcinoma. Radiology and Oncology. 2007; 41(2):72-9. PMID: 0     
  24. McKean H, Miller RC, Jatoi A. Non-traumatic vertebral fractures in patients with locally advanced esophageal cancer: a previously unreported, unrecognized problem. Dis Esophagus. 2007; 20: (2)102-6. PMID: 17439592   DOI: 10.1111/j.1442-2050.2007.00645.x  
  25. Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):410-6. PMID: 17236964   DOI: 10.1016/j.ijrobp.2006.09.030  
  26. Gold DG, Miller RC, Petersen IA, Osborn TG. Radiotherapy for malignancy in patients with scleroderma: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):559-67. PMID: 17236971   DOI: 10.1016/j.ijrobp.2006.09.003  
  27. Foote RL, Brown PD, Garces YI, Okuno SH, Miller RC, Strome SE. Informed consent in advanced laryngeal cancer. Head Neck. 2007 Mar; 29(3):230-5. PMID: 17230562     
  28. Sarkaria JN, Schwingler P, Schild SE, Grogan PT, Mladek AC, Mandrekar SJ, Tan AD, Kobayashi T, Marks RS, Kita H, Miller RC, Limper AH, Leof EB. Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer. J Thorac Oncol. 2007 Aug; 2(8):751-7. PMID: 17762343   DOI: 10.1097/JTO.0b013e3180cc2587  
  29. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol. 2007 Oct 10; 25(29):4581-6. PMID: 17925552   DOI: 10.1200/JCO.2007.12.0170  
  30. Gines A, Cassivi SD, Martenson JA Jr, Schleck C, Deschamps C, Sinicrope FA, Alberts SR, Murray JA, Zinsmeister AR, Vazquez-Sequeiros E, Nichols FC 3rd, Miller RC, Quevedo JF, Allen MS, Alexander JA, Zais T, Haddock MG, Romero Y. Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer. Dis Esophagus. 2008; 21 (3):241-50 PMID: 18430106   PMCID: 2577373   DOI: 10.1111/j.1442-2050.2007.00766.x
  31. Miller R, Iott M, Corsini M. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS Symposium. Int J Radiat Oncol Biol Phys  in press. 2008.      
  32. Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villa S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A, Rare Cancer Network. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecol Oncol. 2008 Feb; 108(2):298-305. Epub 2007 Dec 21 PMID: 18096209   DOI: 10.1016/j.ygyno.2007.10.037  
  33. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, Chmura SJ. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Apr 1; 70(5):1431-7. Epub 2007 Nov 08. PMID: 17996390   DOI: 10.1016/j.ijrobp.2007.08.074  
  34. Gold DG, Miller RC, Pinn ME, Osborn TG, Petersen IA, Brown PD. Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severity. Radiother Oncol. 2008 Apr; 87(1):127-31. Epub 2007 Dec 26. PMID: 18158195   DOI: 10.1016/j.radonc.2007.11.031  
  35. Pinn ME, Gold DG, Petersen IA, Osborn TG, Brown PD, Miller RC. Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys. 2008 Jun 1; 71(2):498-506. Epub 2007 Dec 31. PMID: 18164848   DOI: 10.1016/j.ijrobp.2007.10.014  
  36. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol. 2008 Jul 20; 26(21):3511-6. PMID: 18640932   DOI: 10.1200/JCO.2007.15.8782  
  37. Iott MJ, Corsini MM, Miller RC. Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas. Clin J Oncol Nurs. 2008 Aug; 12(4):599-605. PMID: 18676327   DOI: 10.1188/08.CJON.599-605  
  38. Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol. 2008 Nov 10; 26 (32):5248-53 Epub 2008 Sept 02 PMID: 18768432   PMCID: 2652088   DOI: 10.1200/JCO.2008.17.1546
  39. Stein ME, Bernstein Z, Abacioglu U, Sengoz M, Miller RC, Meirovitz A, Zouhair A, Freixa SV, Poortmans PH, Ash R, Kuten A. Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network. Am J Med Sci. 2008 Dec; 336(6):478-88. PMID: 19092321   DOI: 10.1097/MAJ.0b013e3181731e58  
  40. * Botros M, Quevedo J, Miller RC. Angiosarcoma of the liver after multimodality therapy for gallbladder carcinoma. Radiology and Oncology. 2009; 43(2):126-31. PMID: 0     
  41. Nguyen TD, Azria D, Brochonc D, Poortmans P, Miller RC. Cancers de prostate: Quelle place pour la radiotherapie a visee curative chez les patients age?  Travail coopératif du Rare Cancer Network (RCN). Cancer Radiothérapie.2009;in press:      
  42. Jacobs NL, Que FG, Miller RC, Vege SS, Farnell MB, Jatoi A. Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer. J Gastrointest Cancer. 2009; 40 (1-2):46-50 PMID: 19728180   DOI: 10.1007/s12029-009-9082-y  
  43. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR, Deschamps C. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009 Feb; 87 (2):392-8; discussion 398-9 PMID: 19161745   PMCID: 2930775   DOI: 10.1016/j.athoracsur.2008.11.001
  44. Schomas DA, Miller RC, Donohue JH, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Gunderson LL. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Ann Surg. 2009 Apr; 249(4):588-95. PMID: 19300231   DOI: 10.1097/SLA.0b013e31819ec7e3  
  45. Daniels TB, Pollock BE, Miller RC, Lucchinetti CF, Leavitt JA, Brown PD. Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report. J Neurooncol. 2009 Jun; 93 (2):263-7 Epub 2008 Dec 20 PMID: 19099198   PMCID: 2724634   DOI: 10.1007/s11060-008-9766-3
  46. Pica A, Miller R, Villa S, Kadish SP, Anacak Y, Abusaris H, Ozyigit G, Baumert BG, Zaucha R, Haller G, Weber DC. The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1114-20. Epub 2009 Feb 26. PMID: 19250760   DOI: 10.1016/j.ijrobp.2008.09.034  
  47. Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johnson DH, Green MR, Miller RC, Ley J, Sause WT, Cox JD. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009 Aug 1; 374(9687):379-86. Epub 2009 Jul 24. PMID: 19632716   PMCID: 4407808   DOI: 10.1016/S0140-6736(09)60737-6
  48. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys. 2009 Sep 1; 75(1):150-5. Epub 2009 Mar 16. PMID: 19297105   DOI: 10.1016/j.ijrobp.2008.10.052  
  49. Miller RC, Iott MJ, Corsini MM. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium. Int J Radiat Oncol Biol Phys. 2009 Oct 1; 75(2):364-8. PMID: 19735864   DOI: 10.1016/j.ijrobp.2008.11.069  
  50. Devisetty K, Mell LK, Salama JK, Schomas DA, Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol. 2009 Nov; 93(2):298-301. Epub 2009 Aug 28. PMID: 19717198   DOI: 10.1016/j.radonc.2009.07.006  
  51. Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int J Radiat Oncol Biol Phys. 2009 Nov 1; 75 (3):950-8 PMID: 19801106   DOI: 10.1016/j.ijrobp.2009.04.023  
  52. Neben-Wittich MA, Stauder MC, Quevedo F, Corsini MM, Iott MJ, Miller RC. Adjuvant radiotherapy and chemotherapy for resected pancreatic adenocarcinoma: Review of current evidence. European Journal of Clinical and Medical Oncology. 2010; 2(1). PMID: 0     
  53. Hallemeier CL, Kohli M, Chandan VS, Miller RC, Choo R. Multiple urinary bladder masses from metastatic prostate adenocarcinoma. Rare Tumors. 2010; 2(4):e65. Epub 2010 Dec 31. PMID: 21234257   PMCID: 3019600   DOI: 10.4081/rt.2010.e65
  54. Miller RC. Problems in rare tumor study: A call for papers. Rare Tumors. 2010; 2(2):46-7. PMID: 0     
  55. Igdem S, Spiegel DY, Efstathiou J, Miller RC, Poortmans PM, Koca S, Kilic-Unsal D, Okkan S, Zietman A. Prostatic duct adenocarcinoma: clinical characteristics, treatment options, and outcomes - a Rare Cancer Network study. Onkologie. 2010; 33(4):169-73. Epub 2010 Mar 19. PMID: 20389142   DOI: 10.1159/000288710  
  56. Zhou Y, Boardman LA, Miller RC. Genetic testing for young-onset colorectal cancer: case report and evidence-based clinical guidelines. Radiol Oncol. 2010 Mar; 44 (1):57-61 Epub 2010 Mar 18 PMID: 22933892   PMCID: 3423677   DOI: 10.2478/v10019-010-0005-0
  57. Hsu CC, Herman JM, Corsini MM, Winter JM, Callister MD, Haddock MG, Cameron JL, Pawlik TM, Schulick RD, Wolfgang CL, Laheru DA, Farnell MB, Swartz MJ, Gunderson LL, Miller RC. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Ann Surg Oncol. 2010 Apr; 17(4):981-90. Epub 2010 Jan 20. PMID: 20087786   PMCID: 2840672   DOI: 10.1245/s10434-009-0743-7
  58. Nguyen TD, Azria D, Brochon D, Poortmans P, Miller RC, Scandolaro L, Majewski W, Krengli M, Abacioglu U, Moretti L, Villa S, Akyol F, Jovenin N. Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: a retrospective rare cancer network study. Crit Rev Oncol Hematol. 2010 Apr; 74(1):66-71. Epub 2009 May 05. PMID: 19419885   DOI: 10.1016/j.critrevonc.2009.04.004  
  59. Bardia A, Greeno E, Miller R, Alberts S, Dozois E, Haddock M, Limburg P. Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis? Colorectal Dis. 2010 Apr; 12(4):312-5. Epub 2009 Feb 25. PMID: 19250258   DOI: 10.1111/j.1463-1318.2009.01821.x  
  60. Buyyounouski MK, Price RA, Harris EE, Miller R, Tome W, Schefter T, Parsai EI, Konski AA, Wallner PE. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1297-304. PMID: 20338473   DOI: 10.1016/j.ijrobp.2009.09.078  
  61. Schomas DA, Quevedo JF, Donahue JM, Nichols FC 3rd, Romero Y, Miller RC. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic. Dis Esophagus. 2010 Apr; 23: (3)232-9. PMID: 19515184   DOI: 10.1111/j.1442-2050.2009.00990.x  
  62. Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen, Williams JP, Nichols CR, Einhorn LH, Fossa SD. Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst. 2010 Aug 4; 102(15):1114-30. Epub 2010 Jun 28. PMID: 20585105   PMCID: 2914759   DOI: 10.1093/jnci/djq216
  63. Stauder MC, Miller RC. Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma. Cancers (Basel). 2010 Aug 9; 2 (3):1565-75 Epub 2010 Aug 09 PMID: 24281173   PMCID: 3837322   DOI: 10.3390/cancers2031565
  64. Buyyounouski MK, Balter P, Lewis B, D'Ambrosio DJ, Dilling TJ, Miller RC, Schefter T, Tome W, Harris EE, Price RA, Konski AA, Wallner PE. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys. 2010 Sep 1; 78(1):3-10. Epub 2010 Jul 17. PMID: 20643514   DOI: 10.1016/j.ijrobp.2010.04.010  
  65. Atalar B, Miller RC, Dincbas FO, Geismar JH, Micke O, Akyurek S, Ozyar E. Adult langerhans cell histiocytosis of bones : a rare cancer network study. Acta Orthop Belg. 2010 Oct; 76(5):663-8. PMID: 21138223     
  66. Miller RC, Atherton PJ, Kabat BF, Fredericksen MB, Geno DM, Deschamps C, Jatoi A, Sloan JA, Romero Y. Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. Dig Dis Sci. 2010 Oct; 55 (10):2860-8 Epub 2010 Jan 22 PMID: 20094784   DOI: 10.1007/s10620-009-1100-1  
  67. Mansfield A, Tafur A, Smithedajkul P, Corsini M, Quevedo F, Miller R. Mayo Clinic experience with very rare exocrine pancreatic neoplasms. Pancreas. 2010 Oct; 39(7):972-5. PMID: 20622706   DOI: 10.1097/MPA.0b013e3181df273b  
  68. Lott M, Neben-Wittich M, Quevedo JF, Miller RC. Adjuvant chemoradiotherapy for resected pancreas cancer. World J Gastrointest Surg. 2010 Nov 27; 2 (11):373-80 PMID: 21160900   PMCID: 3000450   DOI: 10.4240/wjgs.v2.i11.373
  69. Haddock MG, Miller RC, Nelson H, Pemberton JH, Dozois EJ, Alberts SR, Gunderson LL. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 1; 79(1):143-50. Epub 2010 Apr 13. PMID: 20395067   DOI: 10.1016/j.ijrobp.2009.10.046  
  70. Narang AK, Miller RC, Hsu CC, Bhatia S, Pawlik TM, Laheru D, Hruban RH, Zhou J, Winter JM, Haddock MG, Donohue JH, Schulick RD, Wolfgang CL, Cameron JL, Herman JM. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiat Oncol. 2011; 6:126. Epub 2011 Sep 28. PMID: 21951377   PMCID: 3204241   DOI: 10.1186/1748-717X-6-126
  71. Onal C, Li YX, Miller RC, Poortmans P, Constantinou N, Weber DC, Atasoy BM, Igdem S, Ozsahin M, Ozyar E. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study. Ann Oncol. 2011 Jan; 22(1):156-64. Epub 2010 Jun 29. PMID: 20587509   DOI: 10.1093/annonc/mdq310  
  72. Winter JM, Narang AK, Mansfield AS, Herman JM, Cameron JL, Laheru D, Eckhauser FE, Olson MT, Hruban RH, Miller RC, Andersen DK. Resectable pancreatic small cell carcinoma. Rare Tumors. 2011 Mar 30; 3 (1):e5 PMID: 21464878   PMCID: 3070453   DOI: 10.4081/rt.2011.e5
  73. Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Stoffel TJ, Haselow RE, Schaefer PL, Bearden JD 3rd, Atherton PJ, Loprinzi CL, Martenson JA. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79 (5):1460-6 Epub 2010 Aug 26 PMID: 20800381   PMCID: 2995007   DOI: 10.1016/j.ijrobp.2010.01.031
  74. Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol. 2011 May; 99 (2):166-71 Epub 2011 May 14 PMID: 21571384   DOI: 10.1016/j.radonc.2011.04.002  
  75. Vos B, Rozema T, Miller RC, Hendlisz A, Van Laethem, Khanfir K, Weber DC, El Nakadi, Van Houtte. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study. Dis Esophagus. 2011 May; 24(4):258-64. Epub 2010 Nov 12. PMID: 21073624   DOI: 10.1111/j.1442-2050.2010.01133.x  
  76. Smith RS, Miller RC. Incidence of brain metastasis in patients with esophageal carcinoma. World J Gastroenterol. 2011 May 21; 17(19):2407-10. PMID: 21633640   PMCID: 3103793   DOI: 10.3748/wjg.v17.i19.2407
  77. Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. J Clin Oncol. 2011 Jun 20; 29(18):2466-73. Epub 2011 May 16. PMID: 21576642   PMCID: 3138631   DOI: 10.1200/JCO.2010.32.4079
  78. Neben-Wittich MA, Atherton PJ, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Loprinzi CL, Burger KN, Martenson JA, Miller RC. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). Int J Radiat Oncol Biol Phys. 2011 Oct 1; 81 (2):397-402 Epub 2010 Oct 01 PMID: 20888137   PMCID: 3365545   DOI: 10.1016/j.ijrobp.2010.05.065
  79. Call JA, Haddock MG, Quevedo JF, Larson DW, Miller RC. Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: efficacy of a low daily dose to clinically negative regions. Radiat Oncol. 2011 Oct 6; 6:134 Epub 2011 Oct 06 PMID: 21978568   PMCID: 3198694   DOI: 10.1186/1748-717X-6-134
  80. Bhatia S, Miszczyk L, Roelandts M, Nguyen TD, Boterberg T, Poortmans P, Vallow L, Dincbas FO, Lassen-Ramshad Y, Botros M, Miller RC. Radiotherapy for marginally resected, unresectable or recurrent giant cell tumor of the bone: a rare cancer network study. Rare Tumors. 2011 Oct 21; 3 (4):e48 Epub 2011 Dec 16 PMID: 22355503   PMCID: 3282453   DOI: 10.4081/rt.2011.e48
  81. Hallemeier CL, Botros M, Corsini MM, Haddock MG, Gunderson LL, Miller RC. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy. Am J Clin Oncol. 2011 Dec; 34(6):567-72. PMID: 21150564   DOI: 10.1097/COC.0b013e3181f946fc  
  82. Thariat J, Kirova Y, Sio T, Choussy O, Vees H, Schick U, Poissonnet G, Saada E, Thyss A, Miller RC. Mucosal Kaposi sarcoma, a rare cancer network study. Rare Tumors. 2012; 4(4):156-61.      
  83. Anacak Y, Miller RC, Constantinou N, Mamusa AM, Epelbaum R, Li Y, Calduch AL, Kowalczyk A, Weber DC, Kadish SP, Bese N, Poortmans P, Kamer S, Ozsahin M. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):315-20. Epub 2010 Nov 13. PMID: 21075560   DOI: 10.1016/j.ijrobp.2010.09.046  
  84. Patel AB, Hallemeier CL, Petersen IA, Jensen AW, Osborn TG, Miller RC. Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control study. Radiat Oncol. 2012 Feb 16; 7:22 PMID: 22340665   PMCID: 3296611   DOI: 10.1186/1748-717X-7-22
  85. Botros M, Chang K, Miller R, Krishnan S, Iott M. Recurrent invasive lobular carcinoma presenting as a ruptured breast implant. Radiol Oncol. 2012 Mar; 46(1):23-7. Epub 2011 Oct 08. PMID: 22933976   PMCID: 3423769   DOI: 10.2478/v10019-011-0032-5
  86. Khanfir K, Kallel A, Villette S, Belkacemi Y, Vautravers C, Nguyen T, Miller R, Li YX, Taghian AG, Boersma L, Poortmans P, Goldberg H, Vees H, Senkus E, Igdem S, Ozsahin M, Jeanneret Sozzi. Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):2118-24. Epub 2011 May 11. PMID: 21570212   DOI: 10.1016/j.ijrobp.2010.12.008  
  87. Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82 (5):e803-9 Epub 2012 Feb 11 PMID: 22330988   DOI: 10.1016/j.ijrobp.2011.11.036  
  88. Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol. 2012 May 3; 7:67 Epub 2012 May 03 PMID: 22553982   PMCID: 3464963   DOI: 10.1186/1748-717X-7-67
  89. Thariat J, Julieron M, Brouchet A, Italiano A, Schouman T, Marcy PY, Odin G, Lacout A, Dassonville O, Peyrottes-Birstwisles I, Miller R, Thyss A, Isambert N. Osteosarcomas of the mandible: are they different from other tumor sites? Crit Rev Oncol Hematol. 2012 Jun; 82(3):280-95. Epub 2011 Aug 24. PMID: 21868246   DOI: 10.1016/j.critrevonc.2011.07.001  
  90. Patel A, Ozsahin M, Mirimanoff RO, Bhatia S, Chang K, Miller RC. The Rare Cancer Network: achievements from 1993 to 2012. Rare Tumors. 2012 Jun 26; 4 (3):e35 Epub 2012 Sept 27 PMID: 23087791   PMCID: 3475942   DOI: 10.4081/rt.2012.e35
  91. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20 (8):1729-35 Epub 2011 Sept 16 PMID: 21922203   PMCID: 3391325   DOI: 10.1007/s00520-011-1266-x
  92. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012 Oct 22; 7:174 PMID: 23083010   PMCID: 3549771   DOI: 10.1186/1748-717X-7-174
  93. Villa S, Miller RC, Krengli M, Abusaris H, Baumert BG, Servagi-Vernat S, Igdem S, Lucas A, Boluda S, Mirimanoff RO. Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN). Clin Transl Oncol. 2012 Nov; 14(11):827-34. Epub 2012 Aug 23. PMID: 22914906   DOI: 10.1007/s12094-012-0869-0  
  94. Barney BM, Olivier KR, Macdonald OK, Fong de Los Santos LE, Miller RC, Haddock MG. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. Am J Clin Oncol. 2012 Dec; 35 (6):537-42 PMID: 21659830   DOI: 10.1097/COC.0b013e31821f876a  
  95. Mayo CS, Zankowski C, Herman M, Miller R, Olivier K, Vincent A, Suominen J. A method to vectorize the dose distribution, the dose volume histogram and create a dose vector histogram. Med Phys. 2013 Jan; 40: (1)011717. PMID: 23298087   DOI: 10.1118/1.4769111  
  96. Call JA, Haddock MG, Quevedo JF, Larson DW, Miller RC. Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center. Pract Radiat Oncol. 2013 Jan-Mar; 3 (1):26-31 Epub 2012 Apr 03 PMID: 24674260   DOI: 10.1016/j.prro.2012.02.005  
  97. Abu Dayyeh BK, Vandamme JJ, Miller RC, Baron TH. Esophageal self-expandable stent material and mesh grid density are the major determining factors of external beam radiation dose perturbation: results from a phantom model. Endoscopy. 2013; 45: (1)42-7. PMID: 23254405   DOI: 10.1055/s-0032-1325960  
  98. Hallemeier CL, Stauder MC, Miller RC, Garces YI, Foote RL, Sarkaria JN, Bauer HJ, Mayo CS, Olivier KR. Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes. J Radiosurg SBRT. 2013; 2 (3):225-233 PMID: 29296365   PMCID: 5658814  
  99. Stauder MC, Romero Y, Kabat B, Atherton PJ, Geno D, Deschamps C, Jatoi A, Sloan JA, Botros M, Jung KW, Arora AS, Miller RC, EABE Registry Consortium. Overall survival and self-reported fatigue in patients with esophageal cancer. Support Care Cancer. 2013 Feb; 21 (2):511-9 Epub 2012 July 29 PMID: 22842921   DOI: 10.1007/s00520-012-1537-1  
  100. Thariat J, Schouman T, Brouchet A, Sarini J, Miller RC, Reychler H, Ray-Coquard I, Italiano A, Verite C, Sohawon S, Bompas E, Dassonville O, Salas S, Aldabbagh K, Maingon P, de La MotteRouge T, Kurtz JE, Usseglio J, Kerbrat P, Raoul G, Lotz JP, Bar-Sela G, Brugieres L, Chaigneau L, Saada E, Odin G, Marcy PY, Thyss A, Julieron M. Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE. Ann Oncol. 2013 Mar; 24(3):824-31. Epub 2012 Nov 06. PMID: 23131392   DOI: 10.1093/annonc/mds507  
  101. Atherton PJ, Halyard MY, Sloan JA, Miller RC, Deming RL, Tai TH, Stien KJ, Martenson JA Jr. Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA. Support Care Cancer. 2013 Apr; 21 (4):1193-9 Epub 2012 Nov 15 PMID: 23151649   PMCID: 4018822   DOI: 10.1007/s00520-012-1648-8
  102. Miller RC, Lodge M, Murad MH, Jones B.  Controversies in clinical trials in proton radiotherapy: the present and the future. Semin Radiat Oncol. 2013 Apr; 23(2):127-33. PMID: 23473690   DOI: 10.1016/j.semradonc.2012.11.004  
  103. Hallemeier CL, Iott MJ, Martenson JA, Haddock MG, Zhao XC, Miller RC.  A pilot study examining circulating interleukin-6 and transforming growth factor-beta levels during pelvic radiation therapy. Am J Clin Oncol. 2013 Aug; 36(4):344-7. PMID: 22772427   DOI: 10.1097/COC.0b013e318248dc36  
  104. Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR.  Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013 Sep 1; 87 (1):73-80 PMID: 23920388   DOI: 10.1016/j.ijrobp.2013.05.012  
  105. Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR.  Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013 Oct; 36(5):509-13. PMID: 22781389   DOI: 10.1097/COC.0b013e3182569189  
  106. Mayo C, Conners S, Warren C, Miller R, Court L, Popple R.  Demonstration of a software design and statistical analysis methodology with application to patient outcomes data sets. Med Phys. 2013 Nov; 40 (11):111718 PMID: 24320426   PMCID: 3815052   DOI: 10.1118/1.4824917
  107. Pohar S, Fung CY, Hopkins S, Miller R, Azawi S, Arnone A, Patton C, Olsen C.  American Society for Radiation Oncology (ASTRO) 2012 Workforce Study: the radiation oncologists' and residents' perspectives. Int J Radiat Oncol Biol Phys. 2013 Dec 1; 87(5):1135-40. Epub 2013 Oct 22. PMID: 24161423   DOI: 10.1016/j.ijrobp.2013.08.038  
  108. Patel K, Stephens EK, Miller RC, Jatoi A.  Incidence and outcomes of chemotherapy and radiation in morbidly obese patients with locally advanced lung and esophageal cancers: a single-institution experience. Cancer Control. 2014 Jan; 21 (1):63-6 PMID: 24357743   DOI: 10.1177/107327481402100109  
  109. Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI.  Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung. Front Oncol. 2014; 4:376 Epub 2015 Jan 14 PMID: 25642416   PMCID: 4294121   DOI: 10.3389/fonc.2014.00376
  110. Sio TT, Mansfield AS, Grotz TE, Graham RP, Molina JR, Que FG, Miller RC.  Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis. J Hum Genet. 2014 Mar; 59 (3):124-8 Epub 2013 Dec 26 PMID: 24369359   PMCID: 3973125   DOI: 10.1038/jhg.2013.132
  111. Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RC, Brown PD, Olivier KR.  Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4 (2):e143-e149 Epub 2013 June 29 PMID: 24890360   PMCID: 4364394   DOI: 10.1016/j.prro.2013.05.006
  112. Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, Feldman DR, Pagliaro LC, Miller RC, Vaughn DJ, Einhorn LH, Cox NJ, Dolan ME, Platinum Study Group.  Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. J Natl Cancer Inst. 2014 Mar 12; 106 (5) PMID: 24623533   PMCID: 4568989   DOI: 10.1093/jnci/dju044
  113. Hallemeier CL, You YN, Larson DW, Dozois EJ, Nelson H, Klein KA, Miller RC, Haddock MG.  Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy. Dis Colon Rectum. 2014 Apr; 57: (4)442-8. PMID: 24608300   DOI: 10.1097/DCR.0000000000000071  
  114. Leenstra JL, Miller RC, Qin R, Martenson JA, Dornfeld KJ, Bearden JD, Puri DR, Stella PJ, Mazurczak MA, Klish MD, Novotny PJ, Foote RL, Loprinzi CL.  Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). J Clin Oncol. 2014 May 20; 32 (15):1571-7 Epub 2014 Apr 14 PMID: 24733799   PMCID: 4026580   DOI: 10.1200/JCO.2013.53.2630
  115. Mirimanoff RO, Ozsahin M, Thariat J, Ozyar E, Schick U, Pehlivan B, Krengli M, Pellanda AF, Vees H, Cai L, Scandolaro L, Belkacemi Y, Villa S, Igdem S, Lutsyk M, Miller RC.  History of the rare cancer network and past research. Rare Tumors. 2014 Jul 30; 6 (3):5462 Epub 2014 Aug 06 PMID: 25276325   PMCID: 4178278   DOI: 10.4081/rt.2014.5462
  116. Ozsahin M, Mirimanoff RO, Thariat J, Sun XS, Atalar B, Lassen-Ramshad Y, Ugurluer G, Krishnan S, Hallemeier C, Houtte PV, Krengli M, Zhang LJ, Chang K, Funk R, Rooney J, Miller RC.  The rare cancer network: ongoing studies and future strategy. Rare Tumors. 2014 Jul 30; 6 (3):5465 Epub 2014 Aug 08 PMID: 25276326   PMCID: 4178279   DOI: 10.4081/rt.2014.5465
  117. Sheehan M, Timlin C, Peach K, Binik A, Puthenparampil W, Lodge M, Kehoe S, Brada M, Burnet N, Clarke S, Crellin A, Dunn M, Fossati P, Harris S, Hocken M, Hope T, Ives J, Kamada T, London AJ, Miller R, Parker M, Pijls-Johannesma M, Savulescu J, Short S, Skene L, Tsujii H, Tuan J, Weijer C.  Position statement on ethics, equipoise and research on charged particle radiation therapy. J Med Ethics. 2014 Aug; 40(8):572-5. Epub 2013 Sep 17. PMID: 24045770   DOI: 10.1136/medethics-2012-101290  
  118. Sio TT, Jensen AR, Miller RC, Fong de los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR.  Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. J Appl Clin Med Phys. 2014 Sep 8; 15 (5):4931 Epub 2014 Sept 08 PMID: 25207580   PMCID: 5711083   DOI: 10.1120/jacmp.v15i5.4931
  119. Morganti AG, Falconi M, van Stiphout RG, Mattiucci GC, Alfieri S, Calvo FA, Dubois JB, Fastner G, Herman JM, Maidment BW 3rd, Miller RC, Regine WF, Reni M, Sharma NK, Ippolito E, Valentini V.  Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):911-7. Epub 2014 Sep 11. PMID: 25220717   DOI: 10.1016/j.ijrobp.2014.07.024  
  120. Liang JJ, Sio TT, Slusser JP, Lennon RJ, Miller RC, Sandhu G, Prasad A.  Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer. JACC Cardiovasc Interv. 2014 Dec; 7(12):1412-20. Epub 2014 Nov 12. PMID: 25459527   DOI: 10.1016/j.jcin.2014.05.035  
  121. Kottschade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, Jakub JW, Bagaria SP, Kumar R, Kaur JS, Morita SY, Moran SL, Nguyen JT, Nguyen EC, Hand JL, Erickson LA, Brewer JD, Baum CL, Miller RC, Swanson DL, Lowe V, Markovic SN.  Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol. 2014 Dec; 37 (6):635-41 PMID: 23563206   PMCID: 4349521   DOI: 10.1097/COC.0b013e3182868e82
  122. Timlin C, Warren DR, Rowland B, Madkhali A, Loken J, Partridge M, Jones B, Kruse J, Miller R.  3D calculation of radiation-induced second cancer risk including dose and tissue response heterogeneities. Med Phys. 2015 Feb; 42: (2)866-76. PMID: 25652499   DOI: 10.1118/1.4905158  
  123. Jayakrishnan R, Chang K, Ugurluer G, Miller RC, Sio TT.  Doxepin for Radiation Therapy-Induced Mucositis Pain in the Treatment of Oral Cancers. Oncol Rev. 2015 Feb 10; 9 (1):290 Epub 2015 Dec 09 PMID: 26779314   PMCID: 4698596   DOI: 10.4081/oncol.2015.290
  124. Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI.  Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiat Oncol. 2015 Feb 18; 10:43 PMID: 25889747   PMCID: 4341868   DOI: 10.1186/s13014-015-0340-9
  125. Lehmann HI, Richter D, Prokesch H, Graeff C, Prall M, Simoniello P, Fournier C, Bauer J, Kaderka R, Weymann A, Szabo G, Sonnenberg K, Constantinescu AM, Johnson SB, Misiri J, Takami M, Miller RC, Herman MG, Asirvatham SJ, Brons S, Jakel O, Haberer T, Debus J, Durante M, Bert C, Packer DL.  Atrioventricular node ablation in Langendorff-perfused porcine hearts using carbon ion particle therapy: methods and an in vivo feasibility investigation for catheter-free ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2015 Apr; 8: (2)429-38. PMID: 25609687   DOI: 10.1161/CIRCEP.114.002436  
  126. Weber DC, Wang Y, Miller R, Villa S, Zaucha R, Pica A, Poortmans P, Anacak Y, Ozygit G, Baumert B, Haller G, Preusser M, Li J.  Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro Oncol. 2015 Apr; 17 (4):588-95 Epub 2014 Oct 09 PMID: 25301811   PMCID: 4483075   DOI: 10.1093/neuonc/nou293
  127. Mattiucci GC, Falconi M, VAN Stiphout RG, Alfieri S, Calvo FA, Herman JM, Maidment BW 3rd, Miller RC, Regine WF, Reni M, Sharma N, Partelli S, Genovesi D, Balducci M, Deodato F, Valentini V, Morganti AG.  Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (>/=75 years) Patients. Anticancer Res. 2015 Jun; 35(6):3441-6. PMID: 26026108     
  128. Birckhead BJ, Peterson JL, Patel AB, Miller RC.  Palliative Radiation for Leukemic Arthropathy from Human T-Cell Lymphoma Virus-associated Adult T-Cell Leukemia Lymphoma. Rare Tumors. 2015 Sep 7; 7 (3):5834 Epub 2015 Sept 07 PMID: 26500728   PMCID: 4600990   DOI: 10.4081/rt.2015.5834
  129. Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, Fuller CD, Pawlik TM, Miller RC, Czito BG, Tuli R, Crane CH, Ben-Josef E, Thomas CR Jr, Herman JM.  Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1100-6. PMID: 26224402   DOI: 10.1245/s10434-015-4685-y  
  130. Anand A, Bues M, Rule WG, Keole SR, Beltran CJ, Yin J, Haddock MG, Hallemeier CL, Miller RC, Ashman JB.  Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer. Radiother Oncol. 2015 Dec; 117 (3):505-8 Epub 2015 Nov 17 PMID: 26597231   DOI: 10.1016/j.radonc.2015.10.027  
  131. Brett CL, Miller DH, Jiang L, Wolfsen HC, Attia S, Hintenlang L, Jagadesh N, Miller RC.  Dedifferentiated liposarcoma of the esophagus: A case report and selected review of the literature Rare Tumors. 2016; 8: (4)201-2.      
  132. Kaleem TA, Schild MH, Miller D, Jha A, Cortese C, Attia S, Miller RC.  Langerhan’s cell sarcoma: Two case reports Rare Tumors. 2016; 8: (1)17-9.      
  133. Sio TT, Vu CC, Sohawon S, Van Houtte P, Thariat J, Novotny PJ, Miller RC, Bar-Sela G.  Extraskeletal Osteosarcoma: An International Rare Cancer Network Study. Am J Clin Oncol. 2016 Feb; 39 (1):32-6 PMID: 24401667   PMCID: 4892767   DOI: 10.1097/COC.0000000000000005
  134. Call JA, Prendergast BM, Jensen LG, Ord CB, Goodman KA, Jacob R, Mell LK, Thomas CR Jr, Jabbour SK, Miller RC.  Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study. Am J Clin Oncol. 2016 Feb; 39: (1)8-12. PMID: 24401669   DOI: 10.1097/COC.0000000000000009  
  135. Sio TT, Merrell KW, Beltran CJ, Ashman JB, Hoeft KA, Miller RC, Whitaker TJ, Wurgler SK, Tryggestad EJ.  Spot-scanned pancreatic stereotactic body proton therapy: A dosimetric feasibility and robustness study. Phys Med. 2016 Feb; 32: (2)331-42. PMID: 26883369   DOI: 10.1016/j.ejmp.2015.12.009  
  136. Merrell KW, Haddock MG, Quevedo JF, Harmsen WS, Kendrick ML, Miller RC, Hallemeier CL.  Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 1; 94: (3)561-70. PMID: 26867884   DOI: 10.1016/j.ijrobp.2015.11.003  
  137. Kaleem TA, Schild MH, Miller D, Jha A, Cortese C, Attia S, Miller RC.  Langerhan's Cell Sarcoma: Two Case Reports. Rare Tumors. 2016 Mar 21; 8 (1):6140 Epub 2016 Apr 06 PMID: 27134713   PMCID: 4827650   DOI: 10.4081/rt.2016.6140
  138. Ugurluer G, Chang K, Gamez ME, Arnett AL, Jayakrishnan R, Miller RC, Sio TT.  Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma. Anticancer Res. 2016 May; 36: (5)2331-8. PMID: 27127140     
  139. Sio TT, Martenson JA Jr, Haddock MG, Novotny PJ, Gores GJ, Alberts SR, Miller RC, Heimbach JK, Rosen CB.  Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma. Am J Clin Oncol. 2016 Jun; 39 (3):271-5 PMID: 24921218   PMCID: 4309741   DOI: 10.1097/COC.0000000000000056
  140. Habboush J, Hollant L, Smart B, Single M, Gaines K, Patel A, Miller R.  Characteristics and Patterns of Rare Malignancies Published in Rare Tumors. Rare Tumors. 2016 Jun 28; 8 (2):6148 Epub 2016 June 28 PMID: 27441071   PMCID: 4935820   DOI: 10.4081/rt.2016.6148
  141. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG.  Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6: (4)e117-26. PMID: 26825250   DOI: 10.1016/j.prro.2015.11.001  
  142. Miller RC, Petereit DG, Sloan JA, Liu H, Martenson JA, Bearden JD 3rd, Sapiente R, Seeger GR, Mowat RB, Liem B, Iott MJ, Loprinzi CL, Alliance for Clinical Trials in Oncology.  N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Jul 15; 95 (4):1168-74 Epub 2016 Apr 23 PMID: 27354129   PMCID: 4955745   DOI: 10.1016/j.ijrobp.2016.01.063
  143. Sio TT, Atherton PJ, Birckhead BJ, Schwartz DJ, Sloan JA, Seisler DK, Martenson JA, Loprinzi CL, Griffin PC, Morton RF, Anders JC, Stoffel TJ, Haselow RE, Mowat RB, Wittich MA, Bearden JD 3rd, Miller RC.  Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]). Support Care Cancer. 2016 Sep; 24 (9):3847-55 Epub 2016 Apr 14 PMID: 27075674   PMCID: 4967382   DOI: 10.1007/s00520-016-3213-3
  144. Ugurluer G, Miller RC, Li Y, Thariat J, Ghadjar P, Schick U, Ozsahin M.  Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study. Rare Tumors. 2016 Sep 5; 8 (3):6502 Epub 2016 Oct 06 PMID: 27746888   PMCID: 5064304   DOI: 10.4081/rt.2016.6502
  145. Sio TT, Wilson ZC, Stauder MC, Bhatia S, Martenson JA, Quevedo JF, Schomas DA, Miller RC.  Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience. Am J Clin Oncol. 2016 Oct; 39 (5):448-52 PMID: 24879469   DOI: 10.1097/COC.0000000000000089  
  146. Sio TT, Liang JJ, Chang K, Novotny PJ, Prasad A, Miller RC.  Outcomes After Curative Thoracic Radiotherapy in Patients With Coronary Artery Disease and Existing Cardiac Stents. Am J Clin Oncol. 2016 Dec; 39 (6):549-555 PMID: 24879471   DOI: 10.1097/COC.0000000000000092  
  147.  Sio TT, Liang JJ, Chang K, Jayakrishnan R, Novotny PJ, Prasad A, Miller RC.  Dosimetric Correlate of Cardiac-Specific Survival Among Patients Undergoing Coronary Artery Stenting After Thoracic Radiotherapy for Cancer. Am J Clin Oncol. 2017 Apr; 40: (2)133-139. PMID: 25268066   DOI: 10.1097/COC.0000000000000135  
  148. Lehmann HI, Deisher AJ, Takami M, Kruse JJ, Song L, Anderson SE, Cusma JT, Parker KD, Johnson SB, Asirvatham SJ, Miller RC, Herman MG, Packer DL.  External Arrhythmia Ablation Using Photon Beams: Ablation of the Atrioventricular Junction in an Intact Animal Model. Circ Arrhythm Electrophysiol. 2017 Apr; 10: (4). PMID: 28408649   DOI: 10.1161/CIRCEP.116.004304  
  149. Habboush Y, Shannon RP, Niazi SK, Hollant L, Single M, Gaines K, Smart B, Chimato NT, Heckman MG, Buskirk SJ, Vallow LA, Tzou KS, Ko SJ, Peterson JL, Biers HA, Day AB, Nelson KA, Sloan JA, Halyard MY, Miller RC.  Patient-reported distress and survival among patients receiving definitive radiation therapy. Adv Radiat Oncol. 2017 Apr-Jun; 2 (2):211-219 Epub 2017 Mar 20 PMID: 28740934   PMCID: 5514245   DOI: 10.1016/j.adro.2017.03.004
  150. Fender EA, Liang JJ, Sio TT, Stulak JM, Lennon RJ, Slusser JP, Ashman JB, Miller RC, Herrmann J, Prasad A, Sandhu GS.  Percutaneous revascularization in patients treated with thoracic radiation for cancer. Am Heart J. 2017 May; 187:98-103. PMID: 28454813   DOI: 10.1016/j.ahj.2017.02.014  
  151. Jagadesh N, Miller DH, Schenk W, Attia S, Sherman CE, Cortese C, May BC, Miller RC.  Recurrent myxoinflammatory fibroblastic sarcoma: a case report. Clin Case Rep. 2017 Jun; 5 (6):871-875 Epub 2017 Apr 20 PMID: 28588829   PMCID: 5458025   DOI: 10.1002/ccr3.949
  152. Miller RC, Goyal S, McClelland S 3rd, Motwani S, Mayo C, Kaleem T, Videtic G, Hintenlang K.  ASTRO's Advances in Radiation Oncology: Success to date and future plans. Adv Radiat Oncol. 2017 Jul-Sep; 2 (3):245-248 Epub 2017 May 26 PMID: 29114588   PMCID: 5605320   DOI: 10.1016/j.adro.2017.05.004
  153. Thariat J, Sio T, Blanchard P, Patel S, Demizu Y, Ampil F, Guihard S, Miller RC, Karlsson U, Krengli M, Giap H, Nguyen N.  Using Proton Beam Therapy in the Elderly Population: A Snapshot of Current Perception and Practice. Int J Radiat Oncol Biol Phys. 2017 Jul 15; 98 (4):840-842 Epub 2017 Jan 06 PMID: 28258888   DOI: 10.1016/j.ijrobp.2017.01.007  
  154. Patel AJ, Tzou KS, Heckman MG, Thomas CS, Lee RJ, Paryani N, Peterson JL, Miller RC, Ko SJ, Vallow LA, Buskirk SJ.  Estimation of PSA Half-Life Following Salvage Radiation Therapy Journal of Cancer Therapy. 2017.      
  155. Patel AB, Tzou KS, Single M, Hollant L, Smart B, Gaines K, Sherman C, Peterson JL, Ko SJ, Vallow LA, Miller RC, Buskirk SJ.  Radiation therapy prophylaxis for heterotopic ossification in non-hip sites.  Journal of Cancer Therapy. 2017.      
  156. Waddle MR, Sio TT, Van Houten HK, Foote RL, Keole SR, Schild SE, Laack N, Daniels TB, Crown W, Shah ND, Miller RC.  Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients. Int J Radiat Oncol Biol Phys. 2017 Dec 1; 99 (5):1078-1082 Epub 2017 Aug 02 PMID: 28939229   DOI: 10.1016/j.ijrobp.2017.07.042  
  157. Fender EA, Chandrashekar P, Liang JJ, Dhar PR, Sio TT, Stulak JM, Lennon RJ, Slusser JP, Ashman JB, Miller RC, Herrmann J, Prasad A, Sandhu GS.  Coronary artery bypass grafting in patients treated with thoracic radiation: a case-control study. Open Heart. 2018; 5 (1):e000766 Epub 2018 Feb 14 PMID: 29531769   PMCID: 5845399   DOI: 10.1136/openhrt-2017-000766
  158. Hintenlang LL, Miller DH, Kaleem T, Patel N, May BC, Tzou KS, Vallow LA, Buskirk SJ, Miller RC, Ko SJ, Jaeckle KA, Trifiletti DM, Peterson JL.  Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literature. J Clin Neurosci. 2018 Feb; 48:118-121 Epub 2017 Nov 26 PMID: 29183682   DOI: 10.1016/j.jocn.2017.11.003  
  159. Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL.  Data collection of patient outcomes: one institution's experience. J Radiat Res. 2018 Mar 1; 59 (suppl_1):i19-i24 PMID: 29538757   PMCID: 5868196   DOI: 10.1093/jrr/rry013
  160. Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC.  Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar; 2 (1):40-48 Epub 2017 Dec 26 PMID: 30225431   PMCID: 6124323   DOI: 10.1016/j.mayocpiqo.2017.11.001
  161. Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI.  American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018 Mar 15; 100 (4):1057-1066 Epub 2017 Dec 15 PMID: 29485047   DOI: 10.1016/j.ijrobp.2017.12.013  
  162. Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT.  Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience. Radiother Oncol. 2018 Apr; 127 (1):96-102 Epub 2018 Jan 17 PMID: 29373196   DOI: 10.1016/j.radonc.2017.12.028  
  163. May JM, Waddle MR, Miller DH, Stross WC, Kaleem TA, May BC, Miller RC, Jiang L, Strong GW, Trifiletti DM, Chaichana KL, Reimer R, Tun HW, Peterson JL.  Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review. Radiat Oncol. 2018 Sep 5; 13 (1):167 Epub 2018 Sept 05 PMID: 30185195   PMCID: 6126020   DOI: 10.1186/s13014-018-1115-x
  164. Matuszak MM, Fuller CD, Yock TI, Hess CB, McNutt T, Jolly S, Gabriel P, Mayo CS, Thor M, Caissie A, Rao A, Owen D, Smith W, Palta J, Kapoor R, Hayman J, Waddle M, Rosenstein B, Miller R, Choi S, Moreno A, Herman J, Feng M.  Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology. Med Phys. 2018 Oct; 45 (10):e811-e819 Epub 2018 Sept 19 PMID: 30229946   DOI: 10.1002/mp.13136  
  165. Lou Y, Dholaria B, Soyano A, Hodge D, Cochuyt J, Manochakian R, Ko SJ, Thomas M, Johnson MM, Patel NM, Miller RC, Adjei AA, Ailawadhi S.  Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers. Cancer Med. 2018 Oct; 7 (10):4932-4942 Epub 2018 Sept 02 PMID: 30175515   PMCID: 6198232   DOI: 10.1002/cam4.1749
  166. McClelland S 3rd, Kaleem T, Bernard ME, Ahmed HZ, Sio TT, Miller RC.  The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States-Part 4: Appalachian patients. Adv Radiat Oncol. 2018 Oct-Dec; 3 (4):471-477 Epub 2018 Aug 10 PMID: 30370344   PMCID: 6200890   DOI: 10.1016/j.adro.2018.08.001
  167. Mayo CS, Phillips M, McNutt TR, Palta J, Dekker A, Miller RC, Xiao Y, Moran JM, Matuszak MM, Gabriel P, Ayan AS, Prisciandaro J, Thor M, Dixit N, Popple R, Killoran J, Kaleba E, Kantor M, Ruan D, Kapoor R, Kessler ML, Lawrence TS.  Treatment data and technical process challenges for practical big data efforts in radiation oncology. Med Phys. 2018 Oct; 45 (10):e793-e810 Epub 2018 Sept 18 PMID: 30226286   DOI: 10.1002/mp.13114  
  168. Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC.  Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Int J Radiat Oncol Biol Phys. 2018 Nov 2 Epub 2018 Nov 02 PMID: 30395904   DOI: 10.1016/j.ijrobp.2018.10.035  
  169. Mattiucci GC, Morganti AG, Cellini F, Buwenge M, Casadei R, Farioli A, Alfieri S, Arcelli A, Bertini F, Calvo FA, Cammelli S, Fuccio L, Giaccherini L, Guido A, Herman JM, Macchia G, Maidment BW 3rd, Miller RC, Minni F, Regine WF, Reni M, Partelli S, Falconi M, Valentini V.  Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Transl Oncol. 2019 Jan; 12 (1):1-7 Epub 2018 Sept 17 PMID: 30237099   PMCID: 6143718   DOI: 10.1016/j.tranon.2018.08.017
  170. Lassen-Ramshad Y, Ozyar E, Alanyali S, Poortmans P, van Houtte P, Sohawon S, Esassolak M, Krengli M, Villa S, Miller R, Demiroz C, Akyurek S, Aggerholm-Pedersen N, Thariat J.  Paraganglioma of the head and neck region, treated with radiation therapy, a Rare Cancer Network study. Head Neck. 2019 Jan 11 [Epub ahead of print] PMID: 30633446   DOI: 10.1002/hed.25611   

Awards and Affiliations

Fellow, Royal Society of Medicine, London, UK, 2015.

Fellow, American Society for Radiation Oncology (ASTRO), 2015.

Mayo School of Health Sciences Outstanding Physician/Scientist Award, 2014.

Fellow, Royal Society of Arts, London, UK, 2002.

RSNA Roentgen Resident/Fellow Research Award, 1998.

Resident Clinical/Basic Research Award, American Society of Therapeutic Radiologists and Oncologists, October 1997.

Young Oncologist Essay Award in Radiation Oncology, American Radium Society, May 1997.

Professional Activity

2001-present       Ad hoc reviewer for 37 journals

2005-2008           Editorial Board Member, Diseases of the Esophagus

2007-2010           Member, Evolving Technology Committee Evaluation Subcommittee, American Society for Radiation Oncology

2008-2014           Chair, Membership Committee, American Society for Radiation Oncology

2011-2013           Chair, Membership committee, American Society for Radiation Oncology

2008-2019           Annual Scientific Meeting Abstract Review Sub-Committees, American Society for Radiation Oncology,

2009-2015           Editor in Chief, Rare Tumors, Pagepress Publications

2011-2013           Member, Workforce Survey Subcommittee, American Society for Radiation Oncology

2011-2013           Member, International Education Committee Task force, American Society for Radiation Oncology

2012-2016           Member, Communications Committee of the Education Council, American Society for Radiation Oncology

2014-present       Member, State Captain Initiative, American Society for Radiation Oncology

2014-present       Member, Research Committee, Radiation Oncology Institute

2018-present      Vice Chair, Research Committee, Radiation Oncology Research Institute

2015-present       Task Group No. 263 - Standardizing Nomenclature - for Radiation Therapy, American Association of Physicists in Medicine

2015-present       Editor in Chief, ASTRO’s Advances in Radiation Oncology, American Society for Radiation Oncology

2018-present       Chair, Annual Scientific Meeting Bioinformatics Track, American Society for Radiation Oncology

2019-present       Chair, Annual Scientific Meeting History, Education, and Social Media, American Society for Radiation Oncology

Edit Icon - Click to update your profileUpdate Your Profile